Home Cart Sign in  
Chemical Structure| 1691249-44-1 Chemical Structure| 1691249-44-1

Structure of (R)-Zanubrutinib
CAS No.: 1691249-44-1

Chemical Structure| 1691249-44-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

(R)-Zanubrutinib is the R-enantiomer of Zanubrutinib, a selective Bruton’s tyrosine kinase (BTK) inhibitor.

Synonyms: (R)-BGB-3111

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Joel Rüegger ; Berend Gagestein ; Antonius P. A. Janssen ; Alexandra Valeanu ; Alger Lazo Mori ; Marielle van der Peet , et al.

Abstract: The human genome encodes 518 protein kinases that are pivotal for drug discovery in various therapeutic areas such as cancer and autoimmune disorders. The majority of kinase inhibitors target the conserved ATP-binding pocket, making it difficult to develop selective inhibitors. To characterize and prioritize kinase-inhibiting drug candidates, efficient methods are desired to determine target engagement across the cellular kinome. In this study, we present CellEKT (Cellular Endogenous Kinase Targeting), an optimized and robust chemical proteomics platform for investigating cellular target engagement of endogenously expressed kinases using the sulfonyl fluoride-based probe XO44 and two new probes ALX005 and ALX011. The optimized workflow enabled the determination of the kinome interaction landscape of covalent and non-covalent drugs across over 300 kinases, expressed as half maximum inhibitory concentration (IC50), which were validated using distinct platforms like phosphoproteomics and NanoBRET. With CellEKT, target engagement profiles were linked to their substrate space. CellEKT has the ability to decrypt drug actions and to guide the discovery and development of drugs.

Keywords: CellEKT ; cellular target engagement ; endogenous kinome profiling ; XO44 ; IC50 ; drug selectivity ; broadspectrum kinase probes ; chemical proteomics ; ABPP

Purchased from AmBeed: ; ; ;

Alternative Products

Product Details of (R)-Zanubrutinib

CAS No. :1691249-44-1
Formula : C27H29N5O3
M.W : 471.55
SMILES Code : O=C(C1=C2NCC[C@H](C3CCN(C(C=C)=O)CC3)N2N=C1C4=CC=C(OC5=CC=CC=C5)C=C4)N
Synonyms :
(R)-BGB-3111
MDL No. :MFCD31567462

Safety of (R)-Zanubrutinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of (R)-Zanubrutinib

RTK

Isoform Comparison

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.12mL

0.42mL

0.21mL

10.60mL

2.12mL

1.06mL

21.21mL

4.24mL

2.12mL

 

Historical Records

Categories